North America Lung Cancer Screening Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Lung Cancer Screening Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Lung Cancer Screening Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Lung Cancer Screening Market Regional Analysis

6.2 North America Lung Cancer Screening Market Revenue 2020-2030 (US$ Million)

6.3 North America Lung Cancer Screening Market Forecast Analysis

7. North America Lung Cancer Screening Market Analysis – by Cancer Type

7.1 Non-Small Cell Lung Cancer

7.1.1 Overview
7.1.2 Non-Small Cell Lung Cancer: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Small Cell Lung Cancer

7.2.1 Overview
7.2.2 Small Cell Lung Cancer: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Lung Cancer Screening Market Analysis – by Technology

8.1 Low-Dose Computed Tomography

8.1.1 Overview
8.1.2 Low-Dose Computed Tomography: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Chest X-Ray

8.2.1 Overview
8.2.2 Chest X-Ray: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Liquid Biopsy

8.3.1 Overview
8.3.2 Liquid Biopsy: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Lung Cancer Screening Market Analysis – by Age Group

9.1 50 & Older and Below 50

9.1.1 Overview
9.1.2 50 & Older and Below 50: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Lung Cancer Screening Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Diagnostic Centers

10.2.1 Overview
10.2.2 Diagnostic Centers: North America Lung Cancer Screening Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Lung Cancer Screening Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Lung Cancer Screening Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Lung Cancer Screening Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Lung Cancer Screening Market Breakdown, by Cancer Type
11.2.1.1.2 US: North America Lung Cancer Screening Market Breakdown, by Technology
11.2.1.1.3 US: North America Lung Cancer Screening Market Breakdown, by Age Group
11.2.1.1.4 US: North America Lung Cancer Screening Market Breakdown, by End User

11.2.1.2 Canada: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Lung Cancer Screening Market Breakdown, by Cancer Type
11.2.1.2.2 Canada: North America Lung Cancer Screening Market Breakdown, by Technology
11.2.1.2.3 Canada: North America Lung Cancer Screening Market Breakdown, by Age Group
11.2.1.2.4 Canada: North America Lung Cancer Screening Market Breakdown, by End User

11.2.1.3 Mexico : North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Lung Cancer Screening Market Breakdown, by Cancer Type
11.2.1.3.2 Mexico : North America Lung Cancer Screening Market Breakdown, by Technology
11.2.1.3.3 Mexico : North America Lung Cancer Screening Market Breakdown, by Age Group
11.2.1.3.4 Mexico : North America Lung Cancer Screening Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 bioAffinity Technologies, Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Canon Medical Systems Corp

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 CVS Health

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 GE HealthCare Technologies Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Intelerad Medical Systems Incorporated

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Koninklijke Philips NV

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 LungLife AI, Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Medtronic Plc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Nuance Communications Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Siemens AG

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Lung Cancer Screening Market

Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)